ILO Links Labour Rights To Journalist Safety; Robotic Bronchoscopy Improves Early Lung Cancer Detection

0
5

ILO LINKS LABOUR RIGHTS TO JOURNALIST SAFETY ON WORLD PRESS FREEDOM DAY — ILO News

GENEVA (ILO News) — To mark World Press Freedom Day, the International Labour Organization (ILO) released a report examining the labour rights dimension of protecting journalists and media workers. Since 1993, more than 1,850 journalists have been killed and hundreds more are currently arbitrarily detained, missing or facing threats. Most of these killings remain unresolved. The report highlights that the safety of journalists depends not only on freedom of expression but also on the enjoyment of fundamental labour rights. “Journalists are key defenders of human and labour rights,” said Frank Hagemann, Director of Sectoral Policies at the ILO. “They are also workers, and labour rights offer an important tool for protecting journalists at work.”

ROBOTIC BRONCHOSCOPY IMPROVES EARLY LUNG CANCER DETECTION — Mayo Clinic, Caribbean, May 2026

A five-year multicenter study from Mayo Clinic suggests robotic-assisted bronchoscopy may provide a less invasive and more precise approach to diagnosing lung cancer, with significant implications for early detection in the Caribbean where lung cancer remains among the leading causes of cancer-related mortality. The study evaluated 2,115 lung lesions in 1,904 patients across Mayo Clinic campuses between 2019 and 2024, reporting 85% sensitivity for malignancy and 76.9% accuracy. Since adoption of robotic bronchoscopy, the proportion of lung cancers diagnosed at an early stage at Mayo Clinic increased from 46% in 2019 to nearly 69% by mid-2024, while diagnoses at advanced stages decreased from 54% to 31%. “Lung cancer survival depends heavily on early detection. Technologies that allow us to diagnose and even treat disease earlier — and with fewer complications — can help improve survival,” said lead author Dr. Sebastian Fernandez-Bussy. Five-year survival for localised lung cancer approaches 67%, compared with approximately 12% for metastatic disease.